Cipla

Cipla recalls over 400 cartons of cancer drug in US: USFDA

New Delhi: A US-based subsidiary of drugmaker Cipla is recalling over 400 cartons of generic anti-cancer medication due to a manufacturing issue, according to the US Food and Drug Administration (USFDA). Warren…